Article thumbnail

Role of Surface Chemistry in Protein Remodeling at the Cell-Material Interface

By Virginia Llopis-Hernández, Patricia Rico, José Ballester-Beltrán, David Moratal and Manuel Salmerón-Sánchez
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3090403
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2003). Adsorption-Induced Conformational Changes in Fibronectin Due to Interactions with Well-Defined Surface Chemistries.
  2. (2001). AP-1 and Cbfa/Runt physically interact and regulate PTH-dependent MMP13 expression in osteoblasts through a new OSE2/AP-1 composite element.
  3. (1994). Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src.
  4. (2011). Bioadhesion of various proteins on random, diblock and triblock copolymer surfaces and the effect of pH conditions.
  5. (2010). Bioartificial matrices for therapeutic vascularization.
  6. (2010). Contractility Modulates Cell Adhesion Strengthening Through Focal Adhesion Kinase and Assembly of Vinculin-Containing Focal Adhesions.
  7. (1996). Control of adhesiondependent cell survival by focal adhesion kinase.
  8. (2006). Cysteine cathepsins: multifunctional enzymes in cancer.
  9. (1992). Degradation of extracellular matrix proteins by human cathepsin B from normal and tumour tissues.
  10. (2007). Effect of wettability and surface functional groups on protein adsorption and cell adhesion using well-defined mixed self-assembled monolayers.
  11. (2010). Effects of surface properties and bioactivation of biomaterials on endothelial cells.
  12. (2007). Fabrication methods of an engineered microenvironment for analysis of cell-biomaterial interactions.
  13. (2000). FAK integrates growth-factor and integrin signals to promote cell migration.
  14. (2009). FAK modulates cell adhesion strengthening via integrin activation.
  15. (2004). FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly.
  16. (2006). Fibrinogen adsorption, platelet adhesion and activation on mixed hydroxyl/ methyl terminated self-assembled monolayers.
  17. (2005). Fibronectin fibril pattern displays the force balance of cell-matrix adhesion.
  18. (1996). Fibronectin matrix formation and the biocompatibility of materials.
  19. (2001). Focal adhesion kinase is involved in mechanosensing during fibroblast migration.
  20. (2005). Focal adhesion kinase: in command and control of cell motility.
  21. (1986). Focal adhesion sites and the removal of substratum-bound fibronectin.
  22. (2004). Garcı ´a AJ
  23. Garcı ´a AJ (2005) Get a grip: integrins in cell-biomaterial interactions.
  24. (2009). Gonza ´lez-Garcı ´a C, Altankov G, Salmero ´nSa ´nchez M
  25. (2007). Increased carcinogenic potential of myeloid tumor cells induced by aberrant TGF-beta-signaling of cathepsin B.
  26. (2006). Inhibition of urokinase type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.
  27. (2002). Integrins: bidirectional, allosteric signaling machines.
  28. (2005). Intracellularcollagen degradationmediated ny uPAR/Endo180is amajorpathway of extracellular matrix turnover during malignancy.
  29. (2009). Matrix metalloproteinase-2 and -9 are induced differently by metal nanoparticles in human monocytes: The role of oxidative stress and protein tyrosine kinase activation.
  30. (2010). Matrix metalloproteinases: What do they not do? New substrates and biological roles identified by murine models and proteomics.
  31. (2007). Matriz metalloproteinases and the regulation of tissue remodelling.
  32. (2004). Mechanical strain induces collagenase-3 (MMP-13) expresio ´n in MC3T3-E1 osteoblastic cells.
  33. (2005). Mediation of biomaterialcell interactions by adsorbed proteins: a review. Tissue Eng 11(1–2):
  34. (2008). MMP-1 (collagenase-1) and MMP-13 (collagenase-3) differentially regulate markers of osteoblastic differentiation in osteogenic cells.
  35. (2009). MMP-9 and CD68+ cells are required for tissue remodeling in response to natural hydroxyapatite.
  36. (2000). Modulating fibroblast adhesion, spreading, and proliferation using self-assembled monolayer films of alkylthiolates on gold.
  37. (1982). Monoclonal antibody against human fibronectin which inhibits cell attachment.
  38. (2009). Monocyte inflammatory and matrix remodeling response modulated by grafted ECM-derived ligand concentration.
  39. (1997). Morphological evidence for different fibronectin receptor organization and function during fibroblast adhesion on hydrophilic and hydrophobic glass substrata.
  40. (1999). MT1 MMP deficient mice develop dwarfism, osteopenia, arthritis and connective tissue disease due to unadequate collagen turnover.
  41. (2003). Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase.
  42. (1997). Myosin light chain kinases.
  43. (1997). Osf/Cbfa1: a transcripcional activator of osteoblast differentiation.
  44. (2009). Polymer brushes and self-assembled monolayers: Versatile platforms to control cell adhesion to biomaterials.
  45. (2003). Protein adsorption on mixtures of hydroxyl- and methyl-terminated alkanethiols self-assembled monolayers.
  46. (2006). Quantitative kinetic analysis of gene expression during human osteoblastic adhesion on orthopaedic materials.
  47. (1995). Reduced cell motility and enhanced focal adhesion contact formation in cells from FAKdeficient mice.
  48. (2000). Regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cells.
  49. (1998). Regulation of the cell cycle by focal adhesion kinase.
  50. (1999). Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells.
  51. (2002). Remodeling of fibrinogen by endothelial cells in dependence of fibronectin matrix assembly. Effect of substratum wettability.
  52. (1994). Reorganization of substratum-bound fibronectin on hydrophilic and hydrophobic materials is related to biocompatibility.
  53. (1999). Requirement of phosphatidylinositol 3-kinase in focal adhesion kinase-promoted cell migration.
  54. (1996). Rho-stimulated contractility drives the formation of stress fibers and focal adhesions.
  55. (2003). ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix.
  56. (2010). Salmero ´n-Sa ´nchez M
  57. (1996). Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn.
  58. (2009). Substrate-induced assembly of fibronectin into networks: influence of surface chemistry and effect on osteoblast adhesion.
  59. (2003). Surface chemistry modulates fibronectin conformation and directs integrin binding and specificity to control cell adhesion.
  60. (2003). Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics.
  61. (2009). The correlation between the adsorption of adhesive proteins and cell behaviour on hidroxi-methyl mixed self-assembled monolayer.
  62. (2010). The effect of matrix characteristics on fibroblasts proliferation in 3D gels.
  63. (2008). The inicial stops of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.
  64. (2010). The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds.
  65. (1981). The removal of extracellular fibronectin from areas of cell-substrate contact.
  66. (1994). The short amino acid sequence ProHis-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function.
  67. (2002). Tissue engineering – Current challenges and expanding opportunities.
  68. (2002). Tissue engineering and reparative medicine.
  69. (2000). Unraveling the role of proteases in cancer.